About Aqemia
Our mission is to design fast innovative drug candidates for dozens of critical diseases.
Aqemia is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline.
Our differentiation lies in our unique quantum and statistical mechanics algorithms fueling a generative artificial intelligence to design novel drug candidates. The disruptive speed and accuracy of our technological platform enables us to scale drug discovery projects just like tech projects. Our endeavors are further underscored by prestigious partnerships with industry leaders, including prominent pharmaceutical companies, FrenchTech ecosystem, and esteemed investment funds.
About Us
We work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team.
Our approach is completely unique in the industry, using AI & deep physics to discover new drugs.
We are a team of +50 people from world-class institutions (AstraZeneca, GSK, Sanofi, Harvard, Princeton, Ecole Normale Supérieure, Ecole Polytechnique, BCG...).
We are also a multinational team: our working language is English.
Our founders boast : 10+ years of research experience at the Ecole Normale Supérieure in Paris, not to mention a stint at Oxford and Cambridge / 10+ years of strategy consulting experience at BCG.
We recently signed a $140 million contract with Sanofi to accelerate their drug discovery.
Global Series A fundraising of up to 60M€.
What can we offer
Competitive salary and BSPCE policy
Hybrid remote working policy: 2 days/week can be worked remotely
Beautiful office in Paris, metro Pasteur (line 12)/Sèvres-Lecourbe (line 6)/Duroc (lines 13 & 10) - Montparnasse station less than 15 minutes walk.
Alan mutuelle, Swile lunch card
Transportation: green participation if you come by bike
If needed: a relocation package to move to Paris, including various services to help you get settled